Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

CStone, the drug’s developer, previously announced similar deals with various pharmaceutical companies to expand sugemalimab ...

Health In Tech announced new partnerships that it says will allow it to introduce a new self-funded health plan. 1 The ...

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

The government agency says X no longer suits its communication needs.

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...